Versatile Technology Platform that is compatible with most Ab discovery and engineering methods.

We target the immune response to specific sites on an antigen, regardless of the target’s immunogenicity, tolerance, or modification status.

The Technology

Our focus is on ‘precision antibodies.’ We want to be able to derive antibodies to specific sites on an antigen at a nearly amino acid resolution. Regardless of target immunogenicity, tolerance, or modification. No longer should a discovery antibody be about ‘what is a good epitope?’ It now becomes ‘where do you want the antibody to bind.’

About us

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

What we do

Precision BioTools uses the best available in vivo and in vitro methods for antibody discovery. This includes both phage display and small animal B-cell cloning methods. Precision BioTools is applying knowledge gained from the past 15 years of human genome sequencing and antibody engineering to produce high affinity and highly specific recombinant antibodies. Precision BioTools’ technology allows us to make antibodies with a targeted precision not obtainable using any other available means.

"Our team is composed of a group of scientists with years of antibody engineering experience. We have developed methods for phage display, immunorepertoire analysis and B cell cloning. Our experience, combined with a desire to tackle some of the more difficult antigen targets is what will make us successful."

- CEO & Founder, Michael P Weiner, Ph.D.